The Implications of Incorporating Nutritional Supplements into the Treatment Regimen for Children Aged 5-12 Years with Visceral Leishmaniasis in Baringo and West Pokot Counties in Kenya
DOI:
https://doi.org/10.47672/ejhs.2284Keywords:
leishmaniasis, micronutrients, minerals, vitamins, implicationsAbstract
Purpose: The purpose of this article is to inform the Ministry of Health Management and all stakeholders in Kenya, the importance of the intervention, fills gaps, and provides guidance on future research direction to accelerate control and eventually eliminate Leishmaniasis. This will also shed new light on the importance of micronutrients and trace elements and their role in immunology, patient outcomes, and the physiology of Visceral Leishmaniasis (VL). The results of this study will also pave way to explore possibilities to fill the research gaps and address challenges like the resistance and relapse of the infection, in patients with VL. Furthermore, this study may help in developing evidence-based strategies related to malnutrition and trace elements, which may be implemented in the eradication program of VL.
Materials and Methods: A quasi-experimental study design was conducted in Kenya from January 2022 to March 2022 in 204 VL-infected children aged 5-12 years. Demographic and clinical data were abstracted from questionnaires and lab forms. Descriptive and inferential analyses were conducted to determine the effect of the intervention on VL outcomes among the study children. Variables with a P-value < 0.05 were considered statistically significant. A total of 204 VL study participants, 102 in each intervention and comparison group were included in this study. Baseline characteristics of the study participants were taken and recorded. The treatment and intervention were started and the trend of BMI, body temperature, vitamins A, B12, C, and D together with minerals Zinc, iron, and iodine levels were monitored weekly for four weeks to determine their effect on the treatment outcomes.
Findings: The results showed that the outcome of administering the micronutrients is significant at 5% level, indicating that the intervention has a favorable effect. The micronutrients increased their levels in the body by increasing BMI, reducing spleen size, and controlling the body temperature of the study participants. In conclusion, the intervention accelerated the recovery from VL.
Implications to Theory, Practice and Policy: This study was informed by the previous researchers' outputs (Mashayekhi Goyonlo V, 2020) indicating that administering the anti-leishmaniasis treatment alone will not yield a favorable treatment outcome in Visceral Leishmaniasis patients and also a study by Nweze JA, Nweze EI (2019) which indicated that malnourished patients with VL had an unfavorable outcome, which was recurrence in 21.4% and also that serum micronutrients levels favor good treatment outcome in Visceral Leishmaniasis. It is therefore important to note that Baringo and West-Pokot Counties, where the present study was conducted, are the Counties in Kenya with the highest percentage of VL patients. The study’s outcomes highlight the potential benefits of micronutrients to improve treatment outcomes in this regard, we recommend that the MOH should encourage the integration of micronutrients with the VL treatment in Baringo and West Pokot Counties. This research provides this new insight indicating that micronutrients affect the nutritional status and the treatment outcomes of VL by controlling body temperature, improving BMI, decreasing spleen size, negative VL tests, and therefore there is need to incorporate micronutrients to the treatment of children with VL. This study also raises several questions that warrant further investigation, such as the research on all the other micronutrients that were not analyzed in this study.
Downloads
References
Njau J, editor Leishmaniasis control in Kenya: Current challenges and future strategies. Geneva Health Forum; 2010.
Ahmed, M. A. A., Ahmed, A. A., Omar, S. M., Adam, G. K., Abdallah, T. M., & Ali, A. A. A. (2016). Epidemiology of visceral leishmaniasis among children in Gadarif hospital, eastern Sudan. BMC Public Health, 16(1), 1–4. https://doi.org/10.1186/s12889-016-3875-2
Ali A, Ashford RW. Visceral leishmaniasis in Ethiopia. IV. Prevalence, incidence, and the relation of infection to disease in an endemic area. Annals of Tropical Medicine and Parasitology 1994; 88:289-293.
Alvar J, den Boer M, Dagne DA. Towards the elimination of visceral leishmaniasis as a public health problem in East Africa: reflections on an enhanced control strategy and a call for action. Lancet Glob Health. 2021;9(12):e1763–e9. pmid:34798033
Amini, Marzyeh, et al. "Biochemical association between essential trace elements and susceptibility to Leishmania major in BALB/c and C57BL/6 mice." Brazilian Journal of Infectious Diseases 13 (2009): 83-85.
Arenas, R., Torres-Guerrero, E., Quintanilla-Cedillo, M. R., & Ruiz-Esmenjaud, J. (2017). Leishmaniasis: A review. F1000Research, 6(May), 1–15. https://doi.org/10.12688/f1000research.11120.1
Badaro R, Jones TE, Lorenco R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson Jr. WDA. Prospective study of visceral leishmaniasis in an endemic area of Brazil. Journal of infectious diseases 1986; 154:640649.
Brodskyn, C. I., & Kamhawi, S. (2018). Biomarkers for Visceral Leishmaniasis in Latin America. 8(July), 1–10. https://doi.org/10.3389/fcimb.2018.00245
Difference-in-differences (DiD) is a popular econometric technique used to estimate the causal effect of a treatment on an outcome. One can run a DiD regression in R using the glm() function with Gaussian as the link function.
Diro, E., Lynen, L., Mohammed, R., Boelaert, M., Hailu, A., & van Griensven, J. (2014). High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia. PLoS Neglected Tropical Diseases, 8(5), 14–17. https://doi.org/10.1371/journal.pntd.0002875
Duthie, M. S., Lison, A., & Courtenay, O. (2018). Advances toward Diagnostic Tools for Managing Visceral Leishmaniasis. Trends in Parasitology, xx, 1–10. https://doi.org/10.1016/j.pt.2018.07.012
Feleke, B.E., Feleke, T.E. Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study. BMC Infect Dis 20, 867 (2020). https://doi.org/10.1186/s12879-020-05615-1
Ghosh P, Roy P, Chaudhuri SJ, Das NK. Epidemiology of post-Kala-azar Dermal Leishmaniasis. Indian J Dermatol. 2021;66(1):12–23. pmid:33911289
Grifferty G, Shirley H, McGloin J, Kahn J, Orriols A, Wamai R. Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review. Res Rep Trop Med. 2021;12:135–51. Pmid: 34188584 https://rpubs.com/phle/r_tutorial_difference_in_differences
Kumar P, Chatterjee M, Das NK. Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis. Indian J Dermatol. 2021 Jan-Feb;66(1):24-33. doi: 10.4103/ijd.IJD_602_20. PMID: 33911290; PMCID: PMC8061484.
Kumar, V., KT, M.F., Sharma, A. et al. The Possible Role of Selected Vitamins and Minerals in the Therapeutic Outcomes of Leishmaniasis. Biol Trace Elem Res 201, 1672–1688 (2023). https://doi.org/10.1007/s12011-022-03311-6
Leishmaniasis Fact Sheet: World Health Organization; 2022 [Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis.
Malafaia G. Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review. Parasite Immunol. 2009 Oct; 31(10):587-96. doi: 10.1111/j.1365-3024.2009.01117.x. PMID: 19751470.
Mann S, Frasca K, Scherrer S, Henao-Martinez AF, Newman S, Ramanan P, et al. A Review of Leishmaniasis: Current Knowledge and Future Directions. Curr Trop Med Rep. 2021;8(2):121–32. Pmid: 33747716
Ngere I, Gufu Boru W, Isack A, Muiruri J, Obonyo M, Matendechero S, et al. Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016. PLoS One. 2020;15(1): e0227697. pmid:31971945
Olaf Müller, M. K. A. (2005). Malnutrition and health in developing countries. CMAJ, 279–286(3), 671–677. https://doi.org/10.1007/s12541-016-0082-0
Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, et al. Global distribution maps of the leishmaniases. Elife. 2014;3. pmid:24972829
Prasad, Ananda S. "Zinc in human health: effect of zinc on immune cells." Molecular medicine 14 (2008): 353-357.
Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S. Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis. 2014;58(10):1424–9. pmid:24585564
The Strategic Plan for Control of Leishmaniasis 2021–2025. Kenya: Republic of Kenya Ministry of Health; 2021.
Wasunna, M., Musa, A., Hailu, A., Khalil, E. A. G., Olobo, J., Juma, R., Wells, S., Alvar, J., & Balasegaram, M. (2016). The Leishmaniasis East Africa Platform (LEAP): Strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(6), 321–323. https://doi.org/10.1093/trstmh/trw031
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ms Ann Iruata Namulen, Dr. John Gachohi, Prof. Anselimo Makokha, Dr. Joseph Mutai
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.